Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Nivolumab|DRUG: Ipilimumab|DRUG: Ipilimumab
Sponsor: The Netherlands Cancer Institute
Collaborators: Bristol-Myers Squibb